Three batches of Gentacan have been recalled following importation by Wadi Altanfeez Commercial Establishment
2026-02-12
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer Gentacan injection Gentamicine Unregistered IS-340 Shivam Enterprises GTA24004 GTA24002
التصنيف
ملف
التاريخ
2025-12-18
اسم المستحضر
Gentacan
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
The SFDA has issued a recall for three batches of Gentacan injection following non-compliance with the requirements stipulated in the Executive Regulations of the Pharmaceutical Establishments System.
التوصيات
For healthcare professionals: Stop dispensing the above batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。